Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Short-term Investments (2017 - 2026)

Integra Lifesciences Holdings' Short-term Investments history spans 5 years, with the latest figure at $28.7 million for Q4 2025.

  • On a quarterly basis, Short-term Investments rose 5.55% to $28.7 million in Q4 2025 year-over-year; TTM through Dec 2025 was $28.7 million, a 5.55% increase, with the full-year FY2025 number at $28.7 million, up 5.55% from a year prior.
  • Short-term Investments hit $28.7 million in Q4 2025 for Integra Lifesciences Holdings, down from $35.7 million in the prior quarter.
  • Over the last five years, Short-term Investments for IART hit a ceiling of $81.7 million in Q2 2024 and a floor of $27.2 million in Q4 2024.
  • Historically, Short-term Investments has averaged $45.5 million across 3 years, with a median of $35.7 million in 2025.
  • The widest YoY moves for Short-term Investments: up 5.55% in 2025, down 56.31% in 2025.
  • Tracing IART's Short-term Investments over 3 years: stood at $32.7 million in 2023, then decreased by 16.84% to $27.2 million in 2024, then rose by 5.55% to $28.7 million in 2025.
  • Business Quant data shows Short-term Investments for IART at $28.7 million in Q4 2025, $35.7 million in Q3 2025, and $35.7 million in Q2 2025.